Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest update is out from Nordic Nanovector ASA ( (DE:8NN) ).
Ekornhuset AS, closely associated with Thor Medical ASA’s chairperson Ludvik Sandnes, acquired 200,000 shares in the company, highlighting significant insider interest and potential confidence in the company’s future prospects. This transaction adheres to market regulation disclosure requirements, reflecting transparency and adherence to financial regulations which may influence stakeholder perceptions and industry positioning.
More about Nordic Nanovector ASA
Thor Medical ASA is an emerging supplier in the radiopharmaceutical industry, focusing on the production of radionuclides, particularly alpha particle emitters derived from naturally occurring thorium. The company utilizes a proprietary process that does not require irradiation or nuclear reactors, offering a reliable, environmentally friendly, and cost-efficient supply solution. Based in Oslo, Norway, Thor Medical is listed on the Oslo Stock Exchange under the ticker ‘TRMED’.
YTD Price Performance: -10.0%
Average Trading Volume: 5,744
Technical Sentiment Consensus Rating: Hold
Current Market Cap: €59.78M
Learn more about 8NN stock on TipRanks’ Stock Analysis page.
